| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031868 |
| Receipt No. | R000036389 |
| Official scientific title of the study | Exploratory test on the influence of pineapple intake on improvement in intestinal bacterial flora |
| Date of disclosure of the study information | 2018/03/23 |
| Last modified on | 2018/04/16 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Exploratory test on the influence of pineapple intake on improvement in intestinal bacterial flora | |
| Title of the study (Brief title) | Exploratory test on the influence of pineapple intake on improvement in intestinal bacterial flora | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Explore the effect of pineapple intake on improvement in intestinal bacterial flora. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intestinal bacterial flora at the beginning of the test or after ingestion of four weeks |
| Key secondary outcomes | General blood biochemical test (total protein, albumin, total cholesterol, blood neutral fat (TG), HDL-cholesterol, LDL-cholesterol, AST(GOT), ALT(GPT), ALP, gamma-GTP, CPK, total bilirubin, uric acid, urea nitrogen, creatinine, sodium, potassium, chlorine, calcium, phosphorus, LDH, HbA1c, glucose), urine test (8-OHdG, creatinine, presumptive salt intake, Na / K ratio, indoxyl sulfate), physical examination (body weight, blood pressure, pulse rate, BMI), and questionnaire at the beginning of the test or after ingestion of 4 weeks |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingest total 100 g of pineapple per day. | |
| Interventions/Control_2 | None | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese women who are 20 years old or more and under 64 years old 3.Persons whose frequency of defecation is 2~4 times per week during the two weeks before the onset of screening |
|||
| Key exclusion criteria | 1.Persons who have a chronic disease and is under medication, or has a serious disease history
2.Persons who are allergic to the test food 3.Persons who participated in other examination during the first month before the start of the exam, or those who plan to participate in other exams following this exam agreement 4.Persons who are breastfeeding, pregnant, scheduled or hoping to be pregnant during the exam period 5.Persons who are judged inappropriate for the exam by the principal investigator |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 0368092722 |
| ishikawa@hc-sys.jp | |
| Public contact | |
| Name of contact person | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 0368092722 |
| Homepage URL | |
| ishikawa@hc-sys.jp | |
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SOLROS Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036389 |